Saranas

Saranas is a Houston, Texas-based medical device company that developed the Early Bird Bleed Monitoring System, a bioimpedance-sensing venous sheath that provides real-time detection and monitoring of internal bleeding complications during vascular access and endovascular procedures such as transcatheter aortic valve replacement. Its customers are hospital interventional cardiology, electrophysiology, and vascular surgery teams; the FDA-cleared device has been used in more than 1,200 patients. Saranas raised a $12.8M Series B led by Baird Capital in 2021 and is listed by investor S3 Ventures as having since been acquired by Johnson & Johnson.